These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26721894)

  • 1. Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells.
    Ruggeri L; Urbani E; André P; Mancusi A; Tosti A; Topini F; Bléry M; Animobono L; Romagné F; Wagtmann N; Velardi A
    Haematologica; 2016 May; 101(5):626-33. PubMed ID: 26721894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
    Kamiya T; Seow SV; Wong D; Robinson M; Campana D
    J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody.
    Gong Y; Germeraad WTV; Zhang X; Wu N; Li B; Janssen L; He Z; Gijbels MJJ; Wu B; Gijsbers BLMG; Olieslagers TI; Bos GMJ; Zheng L; Klein Wolterink RGJ
    Mol Ther; 2024 Aug; 32(8):2711-2727. PubMed ID: 38943249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.
    Godal R; Bachanova V; Gleason M; McCullar V; Yun GH; Cooley S; Verneris MR; McGlave PB; Miller JS
    Biol Blood Marrow Transplant; 2010 May; 16(5):612-21. PubMed ID: 20139023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.
    Sarkar S; van Gelder M; Noort W; Xu Y; Rouschop KM; Groen R; Schouten HC; Tilanus MG; Germeraad WT; Martens AC; Bos GM; Wieten L
    Cancer Immunol Immunother; 2015 Aug; 64(8):951-63. PubMed ID: 25920521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
    Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
    Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.
    Lo Monaco E; Tremante E; Cerboni C; Melucci E; Sibilio L; Zingoni A; Nicotra MR; Natali PG; Giacomini P
    Neoplasia; 2011 Sep; 13(9):822-30. PubMed ID: 21969815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial break in tolerance of NKG2A
    Rathmann S; Keck C; Kreutz C; Weit N; Müller M; Timmer J; Glatzel S; Follo M; Malkovsky M; Werner M; Handgretinger R; Finke J; Fisch P
    Bone Marrow Transplant; 2017 Aug; 52(8):1144-1155. PubMed ID: 28481352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.
    Muccio L; Bertaina A; Falco M; Pende D; Meazza R; Lopez-Botet M; Moretta L; Locatelli F; Moretta A; Della Chiesa M
    Haematologica; 2016 Mar; 101(3):371-81. PubMed ID: 26659918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
    Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus: an unlikely ally in the fight against blood cancers?
    Bigley AB; Baker FL; Simpson RJ
    Clin Exp Immunol; 2018 Sep; 193(3):265-274. PubMed ID: 29737525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal age related change in natural killer cell receptors for MHC class I.
    Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
    Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.